Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001688199-26-000006

Director sold 2,778 shares at $117.55 ($326,554)

  • Director acquired 2,778 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Read Simon Director 2026-08-19 Option exercise 10b5-1 +2,778 $18.36 $51,004 2,778 D
Read Simon Director 2026-08-19 Sale 10b5-1 −2,778 $117.55 $326,554 0 D
Derivatives
Read Simon Director 2026-08-19 Option exercise · Stock Option (Right to Buy) 10b5-1 −2,778 19,445 D
Open-market sales · 2,778 sh · avg $117.55 · $326,554
Loading xslF345X06/ownership.xml…